Physician

Jean-Paul Tran, MD

According to 2025 Medicare claims, Jean-Paul Tran, MD (NPI: 1952365611) practices urology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is ADVANCED UROLOGY INSTITUTE, LLC (NPI: 1023447935; TIN: 46-2439971) and primary practice location at 32308-4894.

Tran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 725 traditional Medicare patients, billed 19,973 HCPCS/CPT codes, and received $321,417 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,797 prescription claims across 858 beneficiaries totaling $2,529,971 in drug costs, led by Xtandi (Enzalutamide). DME data shows 15 claims. Open Payments data shows 109 records totaling $4,885. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $408,872 to $2,529,971. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	970	31,995	$287,130
2016	899	31,047	$295,649
2017	909	30,980	$385,924
2018	954	34,033	$321,412
2019	1,079	38,766	$320,425
2020	893	26,279	$261,026
2021	829	20,429	$287,852
2022	735	20,870	$214,666
2023	717	17,676	$259,415
2024	725	19,973	$321,417

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	601	3,379	$408,872
2016	587	3,432	$492,463
2017	601	3,343	$304,946
2018	619	2,923	$347,981
2019	639	3,079	$384,769
2020	661	3,011	$358,964
2021	677	3,175	$355,285
2022	703	3,254	$485,099
2023	784	3,383	$713,903
2024	858	3,797	$2,529,971

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	30	$9,305
2016	N/R	60	$11,097
2017	N/R	112	$24,811
2018	N/R	80	$12,604
2019	N/R	60	$7,570
2020	N/R	68	$7,454
2021	N/R	12	$12,049
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	15	$5,340

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	81	90	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	518	781	$98
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	390	579	$13
36415	Insertion of needle into vein for collection of blood sample	125	187	$7
81003	Automated urinalysis test	340	431	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	125	3,750	$1,675,106
Erleada	Apalutamide	20	600	$292,159
Myrbetriq	Mirabegron	372	18,359	$270,299
Gemtesa	Vibegron	133	7,490	$117,986
Orgovyx	Relugolix	26	780	$69,178

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	15	$5,340

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	107	$4,885	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$14,921	SN Holdings, LLC

Explore More Providers

FAQ

What Medicare data is available for Jean-Paul Tran, MD?

Tedicare shows public-source Medicare data for Jean-Paul Tran, MD (NPI 1952365611), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jean-Paul Tran, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jean-Paul Tran, MD?

Jean-Paul Tran, MD is linked to ADVANCED UROLOGY INSTITUTE, LLC (billing NPI 1023447935) in the available physician profile data.

Does Jean-Paul Tran, MD have Open Payments data?

Jean-Paul Tran, MD has 109 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.